{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:35:15Z","timestamp":1787506515185,"version":"build-2736575974"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.ymgme.2009.12.002","type":"journal-article","created":{"date-parts":[[2009,12,6]],"date-time":"2009-12-06T17:38:03Z","timestamp":1260121083000},"page":"374-378","source":"Crossref","is-referenced-by-count":47,"title":["Human recombinant palmitoyl-protein thioesterase-1 (PPT1) for preclinical evaluation of enzyme replacement therapy for infantile neuronal ceroid lipofuscinosis"],"prefix":"10.1016","volume":"99","author":[{"given":"Jui-Yun","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra L.","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2009.12.002_bib1","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/376584a0","article-title":"Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis","volume":"376","author":"Vesa","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2009.12.002_bib2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1172\/JCI3112","article-title":"Molecular genetics of palmitoyl-protein thioesterase deficiency in the U.S","volume":"102","author":"Das","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2009.12.002_bib3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ana.1103","article-title":"Adult neuronal ceroid lipofuscinosis with palmitoyl-protein thioesterase deficiency: first adult-onset patients of a childhood disease","volume":"50","author":"van Diggelen","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2009.12.002_bib4","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1212\/01.wnl.0000252825.85947.2f","article-title":"Adult neuronal ceroid lipofuscinosis caused by deficiency in palmitoyl protein thioesterase 1","volume":"68","author":"Ramadan","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2009.12.002_bib5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10048-005-0218-3","article-title":"Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses","volume":"6","author":"Mole","year":"2005","journal-title":"Neurogenetics"},{"issue":"Suppl. A","key":"10.1016\/j.ymgme.2009.12.002_bib6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1053\/ejpn.2000.0465","article-title":"Cardiac pathology in neuronal ceroid lipofuscinoses \u2013 a clinicopathologic correlation in three patients","volume":"5","author":"Hofman","year":"2001","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.ymgme.2009.12.002_bib7","doi-asserted-by":"crossref","first-page":"23212","DOI":"10.1016\/S0021-9258(17)31641-1","article-title":"Molecular cloning and expression of palmitoyl-protein thioesterase","volume":"269","author":"Camp","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2009.12.002_bib8","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1016\/S0021-9258(18)69101-X","article-title":"Proliferin secreted by cultured cells binds to mannose 6-phosphate receptors","volume":"263","author":"Lee","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2009.12.002_bib9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1042\/0264-6021:3570049","article-title":"Production and characterization of recombinant human CLN2 protein for enzyme-replacement therapy in late infantile neuronal ceroid lipofuscinosis","volume":"357","author":"Lin","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgme.2009.12.002_bib10","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0022-2836(82)90103-6","article-title":"Amplification and expression of sequences cotransfected with a modular dihydrofolate reductase complementary dna gene","volume":"159","author":"Kaufman","year":"1982","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ymgme.2009.12.002_bib11","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1006\/mgme.1999.2809","article-title":"A rapid fluorogenic palmitoyl-protein thioesterase assay: pre- and postnatal diagnosis of INCL","volume":"66","author":"van Diggelen","year":"1999","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2009.12.002_bib12","doi-asserted-by":"crossref","first-page":"10046","DOI":"10.1073\/pnas.93.19.10046","article-title":"Lipid thioesters derived from acylated proteins accumulate in infantile neuronal ceroid lipofuscinosis: correction of the defect in lymphoblasts by recombinant palmitoyl-protein thioesterase","volume":"93","author":"Lu","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2009.12.002_bib13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1388-1981(02)00158-0","article-title":"The effects of lysosomotropic agents on normal and INCL cells provide further evidence for the lysosomal nature of palmitoyl-protein thioesterase function","volume":"1583","author":"Lu","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2009.12.002_bib14","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1073\/pnas.73.11.4045","article-title":"Evidence for specific recognition sites mediating clearance of lysosomal enzymes in vivo","volume":"73","author":"Stahl","year":"1976","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2009.12.002_bib15","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1073\/pnas.0712147105","article-title":"Chemically modified beta-glucuronidase crosses blood\u2013brain barrier and clears neuronal storage in murine mucopolysaccharidosis VII","volume":"105","author":"Grubb","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2009.12.002_bib16","doi-asserted-by":"crossref","first-page":"37957","DOI":"10.1074\/jbc.M301225200","article-title":"The crystal structure of palmitoyl protein thioesterase-2 (PPT2) reveals the basis for divergent substrate specificities of the two lysosomal thioesterases, PPT1 and PPT2","volume":"278","author":"Calero","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2009.12.002_bib17","doi-asserted-by":"crossref","first-page":"22566","DOI":"10.1016\/S0021-9258(18)41567-0","article-title":"Purification and properties of a palmitoyl-protein thioesterase that cleaves palmitate from H-Ras","volume":"268","author":"Camp","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2009.12.002_bib18","first-page":"156","article-title":"HuCNS-SC (StemCells)","volume":"8","author":"Taupin","year":"2006","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.ymgme.2009.12.002_bib19","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.stem.2009.05.022","article-title":"Neuroprotection of host cells by human central nervous system stem cells in a mouse model of infantile neuronal ceroid lipofuscinosis","volume":"5","author":"Tamaki","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymgme.2009.12.002_bib20","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.nbd.2004.03.005","article-title":"Adeno-associated virus 2-mediated gene therapy decreases autofluorescent storage material and increases brain mass in a murine model of infantile neuronal ceroid lipofuscinosis","volume":"16","author":"Griffey","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymgme.2009.12.002_bib21","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.ymthe.2005.11.008","article-title":"CNS-directed AAV2-mediated gene therapy ameliorates functional deficits in a murine model of infantile neuronal ceroid lipofuscinosis","volume":"13","author":"Griffey","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2009.12.002_bib22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2350\/07-03-0242.1","article-title":"A murine model of infantile neuronal ceroid lipofuscinosis-ultrastructural evaluation of storage in the central nervous system and viscera","volume":"11","author":"Galvin","year":"2008","journal-title":"Pediatr. Dev. Pathol."},{"key":"10.1016\/j.ymgme.2009.12.002_bib23","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/mt.2008.9","article-title":"Intraventricular enzyme replacement improves disease phenotypes in a mouse model of late infantile neuronal ceroid lipofuscinosis","volume":"16","author":"Chang","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2009.12.002_bib24","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ymgme.2006.12.012","article-title":"Intrathecal enzyme replacement therapy: successful treatment of brain disease via the cerebrospinal fluid","volume":"91","author":"Dickson","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2009.12.002_bib25","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ymgme.2006.10.005","article-title":"Injection of recombinant human sulfamidase into the CSF via the cerebellomedullary cistern in MPS IIIA mice","volume":"90","author":"Hemsley","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2009.12.002_bib26","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/j.1460-9568.2009.06666.x","article-title":"Examination of intravenous and intra-CSF protein delivery for treatment of neurological disease","volume":"29","author":"Hemsley","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ymgme.2009.12.002_bib27","doi-asserted-by":"crossref","first-page":"14777","DOI":"10.1073\/pnas.0506892102","article-title":"Overcoming the blood\u2013brain barrier with high-dose enzyme replacement therapy in murine mucopolysaccharidosis VII","volume":"102","author":"Vogler","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2009.12.002_bib28","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1093\/hmg\/ddn237","article-title":"Reversal of peripheral and central neural storage and ataxia after recombinant enzyme replacement therapy in alpha-mannosidosis mice","volume":"17","author":"Blanz","year":"2008","journal-title":"Hum. Mol. Genet."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671920900523X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671920900523X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T09:47:25Z","timestamp":1634291245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109671920900523X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S109671920900523X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2009.12.002","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}